SSR125543: Clinical Trials

1 trial of SSR125543, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow SSR125543: new trials by email Literature Review of SSR125543 trials Research Report on SSR125543

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
SSR125543, escitalopram, placebo - Major Depression
Phase 2CompletedSanofi5802010-02-012011-04-14

Conditions studied

Depressive Disorder, Major (1)

Sponsors

Sanofi (1)

Countries

Belgium (1)  ·  Canada (1)  ·  Chile (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Slovakia (1)  ·  South Africa (1)  ·  Sweden (1)

NIH funding

2009 (1)